These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31249164)

  • 1. EUS-guided radiofrequency ablation as an alternative to surgery for pancreatic neuroendocrine neoplasms: Who should we treat?
    Larghi A; Rizzatti G; Rimbaş M; Crino SF; Gasbarrini A; Costamagna G
    Endosc Ultrasound; 2019; 8(4):220-226. PubMed ID: 31249164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms.
    Melita G; Pallio S; Tortora A; Crinò SF; Macrì A; Dionigi G
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34203922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis.
    Armellini E; Facciorusso A; Crinò SF
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837560
    [No Abstract]   [Full Text] [Related]  

  • 4. Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma.
    Crinò SF; Partelli S; Napoleon B; Conti Bellocchi MC; Facciorusso A; Salvia R; Forti E; Cintolo M; Mazzola M; Ferrari G; Carrara S; Repici A; Zerbi A; Lania A; Tacelli M; Arcidiacono PG; Falconi M; Larghi A; Rizzatti G; Alfieri S; Panzuto F; Hindryckx P; Berrevoet F; Lapauw B; Lakhtakia S; Sundaram S; Samanta J; Rastogi A; Landoni L
    Dig Liver Dis; 2023 Sep; 55(9):1187-1193. PubMed ID: 37407318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small nonfunctional pancreatic neuroendocrine neoplasms: Time for a step-up treatment approach?
    Rimbaş M; Rizzatti G; Tosoni A; Impagnatiello M; Panzuto F; Larghi A
    Endosc Ultrasound; 2023; 12(1):1-7. PubMed ID: 36510866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database.
    Yang Z; Shi G
    Eur J Surg Oncol; 2022 Oct; 48(10):2181-2187. PubMed ID: 35623986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventional endoscopic ultrasound for pancreatic neuroendocrine neoplasms.
    Rimbaş M; Horumbă M; Rizzatti G; Crinò SF; Gasbarrini A; Costamagna G; Larghi A
    Dig Endosc; 2020 Nov; 32(7):1031-1041. PubMed ID: 31995848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUS-RFA of the pancreas: where are we and future directions.
    Gollapudi LA; Tyberg A
    Transl Gastroenterol Hepatol; 2022; 7():18. PubMed ID: 35548478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EUS-guided radiofrequency ablation for pancreatic insulinoma: experience in 2 tertiary centers.
    Marx M; Trosic-Ivanisevic T; Caillol F; Demartines N; Schoepfer A; Pesenti C; Ratone JP; Robert M; Giovannini M; Godat S
    Gastrointest Endosc; 2022 Jun; 95(6):1256-1263. PubMed ID: 34902374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions.
    Karaisz FG; Elkelany OO; Davies B; Lozanski G; Krishna SG
    Diagnostics (Basel); 2023 Feb; 13(3):. PubMed ID: 36766643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
    Napoléon B; Lisotti A; Caillol F; Gasmi M; Ah-Soune P; Belle A; Charachon A; Cholet F; Eyraud PY; Grandval P; Gonzalez JM; Habersetzer F; Koch S; Le Rhun M; Mangialavori L; Musquer N; Palazzo M; Poincloux L; Privat J; Sportes A; Stouvenot M; Subtil C; Thomassin L; Vanbiervliet G; Vidal G; Vuitton L; Giovannini M; Barthet M
    Gastrointest Endosc; 2023 Sep; 98(3):392-399.e1. PubMed ID: 37059368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports.
    Rossi G; Petrone MC; Capurso G; Partelli S; Falconi M; Arcidiacono PG
    World J Clin Cases; 2022 Jul; 10(19):6514-6519. PubMed ID: 35979317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for management of pancreatic lesions: a systematic review and meta-analysis.
    Fahmawi Y; Mehta A; Abdalhadi H; Merritt L; Mizrahi M
    Transl Gastroenterol Hepatol; 2022; 7():30. PubMed ID: 35892058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EUS-guided radiofrequency and ethanol ablation for pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
    Garg R; Mohammed A; Singh A; Harnegie MP; Rustagi T; Stevens T; Chahal P
    Endosc Ultrasound; 2022; 11(3):170-185. PubMed ID: 35313416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a systematic review of the literature.
    Imperatore N; de Nucci G; Mandelli ED; de Leone A; Zito FP; Lombardi G; Manes G
    Endosc Int Open; 2020 Dec; 8(12):E1759-E1764. PubMed ID: 33269308
    [No Abstract]   [Full Text] [Related]  

  • 16. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos).
    Lakhtakia S; Ramchandani M; Galasso D; Gupta R; Venugopal S; Kalpala R; Reddy DN
    Gastrointest Endosc; 2016 Jan; 83(1):234-9. PubMed ID: 26394384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis.
    Andreasi V; Ricci C; Partelli S; Guarneri G; Ingaldi C; Muffatti F; Crippa S; Casadei R; Falconi M
    J Endocrinol Invest; 2022 Apr; 45(4):705-718. PubMed ID: 34773595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic Ultrasound-Guided Radiofrequency Ablation as an Future Alternative to Pancreatectomy for Pancreatic Metastases from Renal Cell Carcinoma: A Prospective Study.
    Chanez B; Caillol F; Ratone JP; Pesenti C; Rochigneux P; Pignot G; Thomassin J; Brunelle S; Walz J; Salem N; Giovannini M; Gravis G
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome after EUS-guided radiofrequency ablation: Prospective results in pancreatic neuroendocrine tumors and pancreatic cystic neoplasms.
    Barthet M; Giovannini M; Gasmi M; Lesavre N; Boustière C; Napoleon B; LaQuiere A; Koch S; Vanbiervliet G; Gonzalez JM
    Endosc Int Open; 2021 Aug; 9(8):E1178-E1185. PubMed ID: 34447860
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic review of endoscopy ultrasound-guided thermal ablation treatment for pancreatic cancer.
    Testoni SGG; Healey AJ; Dietrich CF; Arcidiacono PG
    Endosc Ultrasound; 2020; 9(2):83-100. PubMed ID: 32295966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.